WHO 药品预认证与检查动态·· 2026-05-26AI 评分47
WHO 第41次原料药（API）邀请：新增丁丙诺啡、美沙酮、纳洛酮（盐酸盐）
41st Invitation of Active Pharmaceutical Ingredients (APIs)
AI 导读
WHO 药品预认证第41次原料药邀请新增三种用于物质使用障碍治疗的盐酸盐原料药：丁丙诺啡（盐酸盐）、美沙酮（盐酸盐）和纳洛酮（盐酸盐）。该动态于 2026 年 5 月 26 日发布。
正文
News
26 May, 2026 - 00:12 (CEST)
The following APIs were added:
- APIs for products used in the treatment of substance use disorders
o Buprenorphine (hydrochloride)
o Methadone (hydrochloride)
o Naloxone (hydrochloride)
来源：WHO 药品预认证与检查动态 · extranet.who.int